News from the MCRC
Researcher Stories
01/02/2021
Meet Danielle Love
She’s doing a non-clinical PhD to investigate the biological effects of proton therapy in lung cancer.
Research Spotlight
01/02/2021
Shorter radiotherapy course reduces risk of bladder cancer returning
Giving people with bladder cancer fewer but larger doses of radiation reduces the risk of their disease returning and should be adopted as the new standard of care, a new study shows.
Researcher Stories
30/01/2021
Meet Dr Helen Clarke
She’s a Senior Specialist Registrar in Obstetrics & Gynaecology and is undertaking a clinical PhD, jointly funded by Cancer Research UK and the NIHR.
Researcher Stories
27/01/2021
Meet Dr Gemma Owens
Researcher Stories
26/01/2021
Meet Dr Anu Datta
He’s a Specialist Registrar in Radiology and is undertaking a clinical PhD which is funded by Cancer Research UK.
Researcher Stories
26/01/2021
Meet Dr Laura Forker
Researcher Stories
25/01/2021
Meet Melanie Seaton
Her PhD investigates human sperm as novel diagnostic and therapeutic tools for the detection and treatment of ovarian cancer lesions at an early, pre-invasive stage in the fallopian tube.
MCRC Blog
15/01/2021
Conference Report: The University of Cambridge’s MB/PhD Symposium 2020
Research Spotlight
11/01/2021
Ultraviolet radiation causes rare type of eye cancer
Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma, according to University of Manchester research
Director's Update
18/12/2020
Director’s Update – December 2020
Partner News
02/12/2020
Professor Caroline Dive is named as Interim Director of the Cancer Research UK Manchester Institute
Research Spotlight
09/11/2020
‘First of its kind’ clinical trial to bring hope to people with lung cancer
Research Spotlight
06/11/2020
Lynch syndrome and endometrial cancer: How our research led to new NICE guidance
The publication of a new national health guideline on Lynch syndrome and endometrial (womb) cancer is an important step forward for women’s health, Lynch syndrome diagnosis, and cancer prevention.
Partner News
02/11/2020
Breakthrough Oncology Development Programme launched
Bruntwood Scitech’s Alderley Park launches breakthrough Oncology Development Programme in collaboration with Cancer Research UK, Innovate UK, Medicines Discovery Catapult and global pharma and healthcare companies
